Fractionalization (fractional ownership) of underlying assets, opens access to wide group of smaller investors that could now invest.
Cost efficiency resulting from process optimization, removal of certain intermediaries, lower transaction fees, and fast delivery of funds.
Improved liquidity and market depth, due to significantly increased size of pool of investors and access to global investors base.
Automation and fast, reliable deal execution due to rapid settlement process of transactions and use of smart contracts.
Improved security, transparency, and ease of audit by conducting recordkeeping on bublic or private blockchain.
Underlying mechanics of capital raise are effectively unchanged
Focus on engaging previously untapped global investor base worldwide
Proprietary utilization of highly secured blockchain technology
Operating given the full regulatory compliance with respective jurisdiction
Issuers can create and issue bonds for placement in international markets, where investors have limited access to higher yielding, reduced risk options.
Create blockchain-based ecosystems supporting sales of services within a client’s business ecosystem.
We offer issuers unique funding options from investors worldwide, which allows issuers to securitize assets and attract eligible investors.
Pre-sell products through utility tokens. Apartments, offices, inventory.
Revenue streams such as royalty, lease, and franchise income can be converted into securities and sold off to investors globally.
Equity/debt issuance and sale, mergers and acquisitions, derivatives based deal structuring.
Creation of Investment Thesis, Business Plan, Whitepaper, Financial Model, Narrative, and Teaser.
In depth research and discussions with Management producing due diligence materials for investors.
Evaluation of financial needs, required types of capital. Term Sheet creation based on desired investment terms, subject to investor interest.
AlphaCapital brings decades of experience in securities law and traditional venture capital, private equity, hedge fund and real estate offerings, as well as public primary and secondary offerings.
AlphaCapital collaborates proactively with leading advisors in each applicable jurisdiction for token offerings.
We regularly advise clients on the various licenses, permits, and filings required in connection of a token offering, as well as deal structuring, AML/KYC processes, and reporting to regulatory oversight agencies.
Our team also has combined over decade of experience in token offerings (utility, currency, and security) from the issuer, agent and platform perspectives.
Release GoToCrowd – a launchpad and secondary market for tokenized securities.
Use Blockchain and Tokenization to bring our investment projects to investors globally.
Through new technology, deliver broader access to previously inaccessible investment opportunities.
Raise proprietary capital for various revolutionary large scale projects and deliver the result for public use.
OncoGenerix is the next generation provider of compliant, high quality, cost effective, contract manufacturing services for injectable products for large pharma and medium size enterprises.
OncoGenerix offers a fully integrated suite of contract manufacturing services including technical transfer, process development, scale-up, equipment and process validation, formulation, filling, lyophilization, inspection, labeling and packaging, meeting the requirements of the US FDA, EMA, CFDA and PMDA.
This is a unique opportunity to invest into large-scale private business alongside large strategic investors.
Introducing a revolutionary investment model, whereby it tokenizes its trophy real-estate asset — a property located at 1551 Broadway, New York, NY 10036.
This building consists of two stories of retail stores, two additional stories of office space, and an impressive outdoor LED billboard system. The property is located at one of the busiest locations in New York, and with tokenization, anyone will be able to own a part of this asset, thereby removing traditional investment barriers that only allowed high-net-worth individuals to acquire ownership up until this point.
AccelPharma plans to build a new sterile injectable drug manufacturing facility within the Opportunity Zone in Valdosta, Georgia. AccelPharma's project is intended to use modular construction technologies to speed up our buildout process in compliance with jurisdictional certification requirements.
AccelPharma will be positioned to deliver high potency oncology drug manufacturing as well as vaccine production, including COVID-19 vaccine (once developed).
Alpha Capital arranges the complete set up of all formalities, enabling us to approach potential investors and promote assets and projects in compliance with applicable regulations.
In addition, Alpha Capital and in-house and external counsel perform required due diligence including corporate structures, company registrations and further required documentation.
We are a complete service provider for raising capital from established and emerging markets quickly and securely.
Alpha Capital prepares all necessary DSO (Digital Security Offering) documentation in addition to the formulation of a financial model, development of smart contracts, implementation of investor dashboard including KYC/AML modules, IT related services, marketing packages, and business consulting.
Alpha Capital comprises a blockchain and business professionals applying new technologies for global capital fundraising.
Technical analysis on which legal, accounting and tax advisors are able to conclude the foundations for a tokenization.
Development of a detailed timeline for all security token stages and requirements.
Development of token type and smart contract parameters.
Ongoing process management and tokenomics model implementation.
